YARROW BIOSCIENCE, INC. Cash and Cash Equivalents, Period Increase (Decrease)
YARROW BIOSCIENCE, INC. (YARW) reported Cash and Cash Equivalents, Period Increase (Decrease) of $15.54 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-01.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-08-01
- YARROW BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $3.10M.
- YARROW BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $12.45M, a 81.78% decline year-over-year.
- YARROW BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$20.69M.
- YARROW BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$3.39M, a 319.71% decline year-over-year.
- YARROW BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $39.30M, a 536.09% increase from fiscal 2017.
- YARROW BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $6.18M.
- YARROW BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$39.78M, a 191.38% decline from fiscal 2015.
- YARROW BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $43.53M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $15.54M 10-Q · filed 2019-08-01 | -$5.14M derived: sum of 3 quarters · filed 2019-08-01 | -$8.53M derived: sum of 4 quarters · filed 2019-08-01 |
| 2019-03-31 | $12.45M 10-Q · filed 2019-05-02 | -$8.24M derived: sum of 2 quarters · filed 2019-05-02 | -$11.63M derived: sum of 3 quarters · filed 2019-05-02 | -$16.57M derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-12-31 | -$20.69M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$24.07M derived: sum of 2 quarters · filed 2019-02-28 | -$29.02M derived: sum of 3 quarters · filed 2019-08-01 | $39.30M 10-K · filed 2019-02-28 |
| 2018-09-30 | -$3.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$8.33M derived: sum of 2 quarters · filed 2019-08-01 | $59.99M 10-Q · filed 2018-11-07 | $55.24M derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-06-30 | -$4.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $63.38M 10-Q · filed 2019-08-01 | $58.63M derived: sum of 3 quarters · filed 2019-08-01 | $60.17M derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-03-31 | $68.32M 10-Q · filed 2019-05-02 | $63.57M derived: sum of 2 quarters · filed 2019-05-02 | $65.11M derived: sum of 3 quarters · filed 2019-05-02 | $72.50M derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | -$4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$3.21M derived: sum of 2 quarters · filed 2019-02-28 | $4.18M derived: sum of 3 quarters · filed 2019-02-28 | $6.18M 10-K · filed 2019-02-28 |
| 2017-09-30 | $1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $8.93M derived: sum of 2 quarters · filed 2018-11-07 | $10.93M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $7.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $9.39M 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | $2.00M 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | -$39.78M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $43.53M 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |